Treatment of pediatric Gram-positive multidrug-resistant infections

Jeffrey Blumer1

  • 1Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-5000, USA. Jeffrey.Blumer@UHhospitals.org

The Journal of Infection
|September 22, 2009
PubMed

Insights

Gram-positive bacterial infections are common in children. Pharmacokinetic and pharmacodynamic data help select appropriate antimicrobial treatments for pediatric patients, addressing resistance and developmental changes.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology
  • Microbiology

Background:

  • Gram-positive organisms cause the majority of bacterial infections in pediatric populations.
  • Antimicrobial therapy for children is often empirical due to evolving resistance patterns.
  • Pediatric patients undergo significant physiological changes affecting antibiotic disposition.

Purpose of the Study:

  • To highlight the importance of pharmacokinetic, pharmacodynamic, and pharmaceutical factors in pediatric antimicrobial selection.
  • To address the challenges in treating Gram-positive infections in infants, children, and adolescents.
  • To emphasize the availability of tools for appropriate antimicrobial agent selection.

Main Methods:

  • Review of pharmacokinetic, pharmacodynamic, and pharmaceutical determinants of antimicrobial efficacy.
  • Analysis of physiological changes in pediatric patients impacting antibiotic disposition.
  • Identification of tools for selecting appropriate antimicrobial agents.

Main Results:

  • Gram-positive infections constitute a significant burden in pediatric community-acquired and hospital-acquired settings.
  • Empirical antimicrobial treatment in children is common despite emerging resistance.
  • Pharmacological principles are crucial for effective antimicrobial therapy in pediatric patients.

Conclusions:

  • Effective antimicrobial treatment for Gram-positive infections in pediatric patients requires consideration of pharmacokinetic, pharmacodynamic, and pharmaceutical data.
  • Understanding developmental changes in antibiotic disposition is essential for optimizing therapy.
  • Utilizing specialized data enables appropriate antimicrobial selection for Gram-positive infections in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...